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Abstract
© 2017 by the authors. Astrocytes are considered to be an important contributor to central
nervous system (CNS) disorders, particularly multiple sclerosis. The transcriptome of these cells
is greatly affected by cytokines released by lymphocytes, penetrating the blood-brain barrier - in
particular, the classical pro-inflammatory cytokine interferon-gamma (IFNγ). We report here the
transcriptomal  profiling  of  astrocytes  treated  using  IFNγ  and  benztropine,  a  putative
remyelinization agent. Our findings indicate that the expression of genes involved in antigen
processing and presentation in astrocytes are significantly upregulated upon IFNγ exposure,
emphasizing the critical role of this cytokine in the redirection of immune response towards self-
antigens. Data reported herein support previous observations that the IFNγ-induced JAK-STAT
signaling pathway may be regarded as a valuable target for pharmaceutical interventions.
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